Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Trial Information

Easily distracted? Disorganized? Maybe it’s Attention Deficit Hyperactivity Disorder.

The study medication is a histamine H3 receptor blocker being investigated by Johnson & Johnson for the treatment of ADHD. There is a 5 out of 6 chance of receiving active medication (1, 3 or 10 mg of study drug, 80 mg Strattera, 54 mg Concerta or inactive drug. There are 8 visits to our office over the course of 8 weeks. The entire study including blood draws, physical exams, ECGs and study medication are provided at no cost.

Patient Inclusion Criteria:

• Subjects must be male or female between 18-55 years of age.
• Subjects must be physically healthy on the basis of clinical laboratory tests, medical history, ECG, and vital signs performed at screening visit.
• Both women and men must use appropriate form of birth control (double-barrier, oral contraceptives, etc) during the course of the study

Patient Exclusion Criteria:

• Subjects who have a prior demonstrated non-response to 2 stimulants
• Pregnant or breast feeding
• Subjects with a family history of, or at high risk for cardiovascular disease
• Current or past history of myocardial infarction, stroke, angina pectoris, cardiac arrhythmias, or cardiomyopathy
• Current or past history of seizures or glaucoma
• Subjects who currently have confirmed cancer or malignancy (except for basal cell carcinoma or squamous cell carcinoma)

Meghan Tedesco, Clinical Research Coordinator
Bay Area Research Institute
3736 Mt. Diablo Blvd., Suite 204
Lafayette, CA 94549
Phone: (925) 283-9006
Fax: (925) 283-9007
EMail: Meghan@BayAreaResearch.com

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.